Ribavirin is used for: Chronic hepatitis C.
Recorded in the NepalDoc medicine catalog for Ribavirin.
Ribavirin capsules are a nucleoside analogue indicated in combination with interferon alfa-2b (pegylated and nonpegylated) for the treatment of Chronic Hepatitis C (CHC) in patients 3 years of age or older with compensated liver disease.
From the U.S. FDA-approved label for Ribavirin. Full label: DailyMed.
Ribavirin capsules are a nucleoside analogue indicated in combination with interferon alfa-2b (pegylated and nonpegylated) for the treatment of Chronic Hepatitis C (CHC) in patients 3 years of age or older with compensated liver disease. Patients with the following characteristics are less likely to benefit from re-treatment after failing a course of therapy: previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and genotype 1 infection. The following points should be considered when initiating ribavirin capsules combination therapy with PegIntron ® or INTRON A ®: Combination therapy with ribavirin capsules/PegIntron is preferred over ribavirin capsules/INTRON A as this combination provides substantially better response rates.
From the U.S. FDA-approved label for Ribavirin. Full label: DailyMed.
Ribavirin capsules are administered according to body weight. Dose reduction or discontinuation is recommended in patients experiencing certain adverse reactions or renal dysfunction. 2.1 General Dosing Information Do not open, crush or break ribavirin capsules.
Directions from the U.S. FDA-approved label for Ribavirin — your doctor or pharmacist may advise differently.
Ribavirin capsules combination therapy is contraindicated in: pregnancy. Ribavirin capsules may cause fetal harm when administered to a pregnant woman. Ribavirin capsules are contraindicated in women who are pregnant or planning to become pregnant. If a patient becomes pregnant while taking ribavirin capsules, the patient should be apprised of the potential hazard to the fetus.
Excerpt from the U.S. FDA-approved label for Ribavirin. Talk to a pharmacist or doctor before use.
Embryo-Fetal Toxicity: May cause fetal harm. Patients should have a negative pregnancy test prior to therapy and use effective contraception and undergo periodic pregnancy tests. Patients exhibiting the following conditions should be closely monitored and may require dose reduction or discontinuation of therapy: Hemolytic anemia may occur with a significant initial drop in hemoglobin. Pulmonary infiltrates or pulmonary function impairment. New or worsening ophthalmologic disorders. Severe decreases in neutrophil and platelet counts, and hematologic, endocrine (e.g., TSH), and hepatic abnormalities.
Warnings and precautions excerpt from the U.S. FDA-approved label for Ribavirin — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse drug reactions are discussed in other sections of the labeling: Embryo-Fetal Toxicity Anemia Pancreatitis Pulmonary Disorders Ophthalmic Disorders Dental and Periodontal Disorders Impact on Growth in Pediatric Patients Hemolytic anemia occurred in more than 10% of adult patients receiving ribavirin/PegIntron or INTRON A combination therapy.
Excerpt from the U.S. FDA-approved label for Ribavirin — not a complete list. Talk to a pharmacist or doctor about side effects.
Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label for Ribavirin.
What is Ribacip?
Ribacip 200mg Capsule is a Ribavirin medicine made by Cipla Ltd. It comes as 200mg Capsule.
What is Ribacip used for?
Ribavirin is used for Chronic hepatitis C.
What is the generic name of Ribacip?
The generic name of Ribacip is Ribavirin.
What are the side effects of Ribavirin?
The following serious adverse drug reactions are discussed in other sections of the labeling: Embryo-Fetal Toxicity Anemia Pancreatitis Pulmonary Disorders Ophthalmic Disorders Dental and Periodontal Disorders Impact on Growth in Pediatric Patients Hemolytic anemia occurred in more than 10% of adult patients receiving ribavirin/PegIntron or INTRON A combination therapy.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
